Response‐adapted zanubrutinib and tislelizumab as a potential strategy to enhance CD19 CAR T‐cell therapy in relapsed/refractory large B‐cell lymphoma: A retrospective observational study.
Saved in:
| Title: | Response‐adapted zanubrutinib and tislelizumab as a potential strategy to enhance CD19 CAR T‐cell therapy in relapsed/refractory large B‐cell lymphoma: A retrospective observational study. |
|---|---|
| Authors: | Shen, Rong1 (AUTHOR), Cao, Wei‐Guo2 (AUTHOR), Wang, Li1,3 (AUTHOR), Sheng, Ling‐Shuang1 (AUTHOR), Zhang, Yi‐Lun1 (AUTHOR), Wu, Wen1 (AUTHOR), Xu, Peng‐Peng1 (AUTHOR), Cheng, Shu1 (AUTHOR), Liu, Meng‐Ke1 (AUTHOR), Dong, Yan1 (AUTHOR), Wang, Yue1 (AUTHOR), Weng, Xiang‐Qin1 (AUTHOR), Jiang, Xu‐Feng4 (AUTHOR), Song, Qi5 (AUTHOR), Yi, Hong‐Mei6 (AUTHOR), Li, Lei7 (AUTHOR), Chen, Sheng8 (AUTHOR), Yan, Zi‐Xun1 (AUTHOR) yanzixun125@163.com, Zhao, Wei‐Li1,3 (AUTHOR) zhao.weili@yahoo.com |
| Source: | Clinical & Translational Medicine. Apr2025, Vol. 15 Issue 4, p1-14. 14p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 184768257 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Response‐adapted zanubrutinib and tislelizumab as a potential strategy to enhance CD19 CAR T‐cell therapy in relapsed/refractory large B‐cell lymphoma: A retrospective observational study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Shen%2C+Rong%22">Shen, Rong</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cao%2C+Wei‐Guo%22">Cao, Wei‐Guo</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Li%22">Wang, Li</searchLink><relatesTo>1,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sheng%2C+Ling‐Shuang%22">Sheng, Ling‐Shuang</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhang%2C+Yi‐Lun%22">Zhang, Yi‐Lun</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wu%2C+Wen%22">Wu, Wen</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Xu%2C+Peng‐Peng%22">Xu, Peng‐Peng</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cheng%2C+Shu%22">Cheng, Shu</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liu%2C+Meng‐Ke%22">Liu, Meng‐Ke</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dong%2C+Yan%22">Dong, Yan</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Yue%22">Wang, Yue</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Weng%2C+Xiang‐Qin%22">Weng, Xiang‐Qin</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jiang%2C+Xu‐Feng%22">Jiang, Xu‐Feng</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Song%2C+Qi%22">Song, Qi</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yi%2C+Hong‐Mei%22">Yi, Hong‐Mei</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Li%2C+Lei%22">Li, Lei</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chen%2C+Sheng%22">Chen, Sheng</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yan%2C+Zi‐Xun%22">Yan, Zi‐Xun</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> yanzixun125@163.com</i><br /><searchLink fieldCode="AR" term="%22Zhao%2C+Wei‐Li%22">Zhao, Wei‐Li</searchLink><relatesTo>1,3</relatesTo> (AUTHOR)<i> zhao.weili@yahoo.com</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Clinical+%26+Translational+Medicine%22">Clinical & Translational Medicine</searchLink>. Apr2025, Vol. 15 Issue 4, p1-14. 14p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=184768257 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/ctm2.70310 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 14 StartPage: 1 Titles: – TitleFull: Response‐adapted zanubrutinib and tislelizumab as a potential strategy to enhance CD19 CAR T‐cell therapy in relapsed/refractory large B‐cell lymphoma: A retrospective observational study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Shen, Rong – PersonEntity: Name: NameFull: Cao, Wei‐Guo – PersonEntity: Name: NameFull: Wang, Li – PersonEntity: Name: NameFull: Sheng, Ling‐Shuang – PersonEntity: Name: NameFull: Zhang, Yi‐Lun – PersonEntity: Name: NameFull: Wu, Wen – PersonEntity: Name: NameFull: Xu, Peng‐Peng – PersonEntity: Name: NameFull: Cheng, Shu – PersonEntity: Name: NameFull: Liu, Meng‐Ke – PersonEntity: Name: NameFull: Dong, Yan – PersonEntity: Name: NameFull: Wang, Yue – PersonEntity: Name: NameFull: Weng, Xiang‐Qin – PersonEntity: Name: NameFull: Jiang, Xu‐Feng – PersonEntity: Name: NameFull: Song, Qi – PersonEntity: Name: NameFull: Yi, Hong‐Mei – PersonEntity: Name: NameFull: Li, Lei – PersonEntity: Name: NameFull: Chen, Sheng – PersonEntity: Name: NameFull: Yan, Zi‐Xun – PersonEntity: Name: NameFull: Zhao, Wei‐Li IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: Apr2025 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 20011326 Numbering: – Type: volume Value: 15 – Type: issue Value: 4 Titles: – TitleFull: Clinical & Translational Medicine Type: main |
| ResultId | 1 |
